Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation | MicrobiomeTrials← Back to trialsNCT06282952
Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-03-31Est. Completion: 2031-03-31
Enrollment target: 460 participants Locations- Oulu University Hospital, Oulu, Finland
Other microbiome trials you might be interested in
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Gastro-Intestinal Disorder
Currently, ANSM recommendations govern FMT (Fecal Microbiota Transplantation) in clinical trials. The collection and val…
Paris, FranceEst. completion May 2030
Hepatocellular CarcinomaHepatocellular Cancer
Liver Diseases
Liver Cancer
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide and is frequently diag…
Roma, ItalyEst. completion Sep 2028